SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-007242
Filing Date
2018-02-07
Accepted
2018-02-07 16:21:05
Documents
5
Period of Report
2018-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-5588_18k.htm 8-K 29483
2 EX-10.1 a18-5588_1ex10d1.htm EX-10.1 20221
3 EX-10.2 a18-5588_1ex10d2.htm EX-10.2 39402
4 GRAPHIC g55881kmi001.jpg GRAPHIC 3046
5 GRAPHIC g55881kki001.jpg GRAPHIC 3046
  Complete submission text file 0001104659-18-007242.txt   99212
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 18581385
SIC: 2834 Pharmaceutical Preparations